65 related articles for article (PubMed ID: 19329378)
1. Prostate-specific antigen (PSA) in serum in relation to blood lead concentration and alcohol consumption in men.
Pizent A; Colak B; Kljaković Z; Telisman S
Arh Hig Rada Toksikol; 2009 Mar; 60(1):69-78. PubMed ID: 19329378
[TBL] [Abstract][Full Text] [Related]
2. Blood pressure in relation to biomarkers of lead, cadmium, copper, zinc, and selenium in men without occupational exposure to metals.
Telisman S; Jurasović J; Pizent A; Cvitković P
Environ Res; 2001 Oct; 87(2):57-68. PubMed ID: 11683589
[TBL] [Abstract][Full Text] [Related]
3. Reproductive toxicity of low-level lead exposure in men.
Telisman S; Colak B; Pizent A; Jurasović J; Cvitković P
Environ Res; 2007 Oct; 105(2):256-66. PubMed ID: 17632096
[TBL] [Abstract][Full Text] [Related]
4. [Plasma concentration of selected neoplastic markers in persons occupationally exposed to arsenic and heavy metals].
Szymańska-Chabowska A; Antonowicz-Juchniewicz J; Andrzejak R
Med Pr; 2004; 55(4):313-20. PubMed ID: 15620040
[TBL] [Abstract][Full Text] [Related]
5. Serum calcium, zinc, and copper in relation to biomarkers of lead and cadmium in men.
Pizent A; Jurasović J; Telisman S
J Trace Elem Med Biol; 2003; 17(3):199-205. PubMed ID: 14968933
[TBL] [Abstract][Full Text] [Related]
6. Exposure to heavy metal elements may significantly increase serum prostate-specific antigen levels with overdosed dietary zinc.
Fang Y; Chen C; Chen X; Song J; Feng S; Li Z; Li Z; Xiong Y; Zhang Q; Su H; Liu H; Zhu G; Hu B; Wang W; Liu Z; Jiao K; Zhang C; Zhang F; Jiang K; He J; Sun Z; Yuan D; Chen W; Zhu J
Ecotoxicol Environ Saf; 2024 Mar; 272():116080. PubMed ID: 38350215
[TBL] [Abstract][Full Text] [Related]
7. Association between urinary arsenic, blood cadmium, blood lead, and blood mercury levels and serum prostate-specific antigen in a population-based cohort of men in the United States.
Wu H; Wang M; Raman JD; McDonald AC
PLoS One; 2021; 16(4):e0250744. PubMed ID: 33891655
[TBL] [Abstract][Full Text] [Related]
8. Association of toxic and essential metals with atopy markers and ventilatory lung function in women and men.
Pizent A; Macan J; Jurasović J; Varnai VM; Milković-Kraus S; Kanceljak-Macan B
Sci Total Environ; 2008 Feb; 390(2-3):369-76. PubMed ID: 18045657
[TBL] [Abstract][Full Text] [Related]
9. Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasia.
Paus E; Nilsson O; Børmer OP; Fosså SD; Otnes B; Skovlund E
J Urol; 1998 May; 159(5):1599-605. PubMed ID: 9554362
[TBL] [Abstract][Full Text] [Related]
10. [Activity of gamma-glutamyltransferase in blood of smoking and non-smoking smelters].
Milnerowicz H; Bizoń A; Stasiak K
Przegl Lek; 2010; 67(10):910-3. PubMed ID: 21360925
[TBL] [Abstract][Full Text] [Related]
11. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
[TBL] [Abstract][Full Text] [Related]
12. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
Stamey TA; Johnstone IM; McNeal JE; Lu AY; Yemoto CM
J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen levels in relation to cadmium exposure and zinc intake: results from the 2001-2002 National Health and Nutrition Examination Survey.
van Wijngaarden E; Singer EA; Palapattu GS
Prostate; 2008 Feb; 68(2):122-8. PubMed ID: 18044729
[TBL] [Abstract][Full Text] [Related]
14. Prostate specific-antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer.
Chun FK; Perrotte P; Briganti A; Benayoun S; Lebeau T; Ramirez A; Lewinshtein DJ; Valiquette L; Guay JP; Karakiewicz PI
BJU Int; 2006 Jul; 98(1):50-3. PubMed ID: 16831142
[TBL] [Abstract][Full Text] [Related]
15. Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old.
Loeb S; Roehl KA; Antenor JA; Catalona WJ; Suarez BK; Nadler RB
Urology; 2006 Feb; 67(2):316-20. PubMed ID: 16442597
[TBL] [Abstract][Full Text] [Related]
16. Relationship between serum prostate-specific antigen levels and body mass index in healthy younger men.
Ahn JO; Ku JH
Urology; 2006 Sep; 68(3):570-4. PubMed ID: 16979743
[TBL] [Abstract][Full Text] [Related]
17. Volume-based evaluation of serum assays for new prostate-specific antigen isoforms in the detection of prostate cancer.
Naya Y; Fritsche HA; Bhadkamkar VA; Mikolajczyk SD; Rittenhouse HG; Babaian RJ
Urology; 2004 Mar; 63(3):492-8. PubMed ID: 15028444
[TBL] [Abstract][Full Text] [Related]
18. Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial.
D'Amico AV; Roehrborn CG
Lancet Oncol; 2007 Jan; 8(1):21-5. PubMed ID: 17196507
[TBL] [Abstract][Full Text] [Related]
19. [The effect of occupational exposure to heavy metals and arsenic on serum concentrations of carotenoids in copper foundry workers].
Chlebda E; Antonowicz-Juchniewicz J; Andrzejak R
Med Pr; 2004; 55(5):389-401. PubMed ID: 15768892
[TBL] [Abstract][Full Text] [Related]
20. Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer: A pathological analysis.
Partin AW; Criley SR; Subong EN; Zincke H; Walsh PC; Oesterling JE
J Urol; 1996 Apr; 155(4):1336-9. PubMed ID: 8632568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
